CliffBio
small molecule

XACIATO

CLINDAMYCIN PHOSPHATE

Loss of exclusivitySeptember 2036latest FDA-listed patent expiry
CompanyOrganon →View the full company profile on CliffBio

Drug detail

Brand nameXACIATO
Active ingredientCLINDAMYCIN PHOSPHATE
StrengthEQ 2% BASE
Dosage formGEL
RouteVAGINAL
ModalitySmall molecule
FDA approvalDecember 2021
Marketing statusRX

Listed patents

PatentExpiresType
11129896September 2036use U-3293
12303563September 2036product

Regulatory exclusivity

CodeExpires
GAINDecember 2029
NPDecember 2024

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

XACIATO patent cliff — loss of exclusivity September 2036 | CliffBio